1 / 36

Protamine Induced Pulmonary Hypertension

Protamine Induced Pulmonary Hypertension. Presented by Ri 陸尊惠 /Ri 黃崧溪 Supervised by CR 林子富. Basic Data. Name: 王嚴 Age: 45 Gender: Male Chart number: 4221159 Date of admission: 3/28. Chief complaint. Intermittent fever for more than 2 months. Present Illness.

Download Presentation

Protamine Induced Pulmonary Hypertension

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Protamine Induced Pulmonary Hypertension Presented by Ri陸尊惠/Ri黃崧溪 Supervised by CR林子富

  2. Basic Data • Name: 王嚴 • Age: 45 • Gender: Male • Chart number: 4221159 • Date of admission: 3/28

  3. Chief complaint • Intermittent fever for more than 2 months

  4. Present Illness • Intermittent fever for more than 2 months • Hematuria • Poor appetite, general weakness in recent weeks • Body weight loss (10 kg in recent 7 months) • Mild cough

  5. Past History • ESRD (drug abuse related) s/p renal transplantation in Feb 2004 with graft failure s/p T1W hemodialysis since Aug 2004 • No immunosuppressant or steroid use since August 2004 • DM (-), hypertension (+) • HBV (+), HCV (+)

  6. Physical Examination • Conscious: clear • Vital signs: BT 37.1°C, PR 105, BP 100/45 mmHg, SpO2 98% • HEENT: pink conjunctiva, anicteric sclera • Chest: symmetric expansion, clear breathing sound • Heart: regular heart beat, grade 3/6 diastolic murmur at apex noted at ward • Abdomen: flat and soft, no tenderness, no shifting dullness, no rebound pain • Extremities: Right forearm AVF

  7. Laboratory Data

  8. Initial Impression • R/O intraabdominal infection • R/O chronic rejection • R/O occult infection • ESRD under hemodialysis TIW • FUO

  9. Cardiac echo (4/1) • AV vegetation (a shaggy mass 6x10mm at LCC of AV) • Normal mitral valve morphology • Severe AR • Concentric LVH • Small amount of pericardial effusion • LVEF: 68% • Pulmonary hypertension • Suspect infective endocarditis

  10. Treatment Course • Blood cultures were negative for pathogens • CVS consultation: antibiotic treatment for at least 2 weeks then elective surgery for AVR; emergent operation indicated if heart failure s/s flare-up or uncontrolled infection • Fever (up to 39°C+) noted despite antibiotics since 3/31 (Penicillin + Gentamicin -> Rocephin -> Cravit + Amikin)

  11. TEE (4/29) • An oscillating hyperechoic nodule (0.50 x 0.55cm) was seen on LCC of AV; a vegetation cannot be ruled out • Peri-aortic root space with fluid accumulation and extension to aorto-mitral intervalvular fibrosa • AR, moderate-severe • MR, moderate • TR, moderate • PR, moderate • Impression: IE with disease progression

  12. Preoperative Evaluation • Basic Data • 45 year-old male • BW: 61.8 kg • BH: 161 cm • Past History • Hypertension, HBV carrier, ESRD s/p renal transplantation and graft failure, under H/D, cigarette smoking 1 ppd • Laboratory Data • WBC 11970, Hb 8.8, BUN/Cr 37.1/4.0 • Clinical Diagnosis: Infective endocarditis • Operation proposed: AVR • Operator: 許榮彬 • Date of operation: 94/5/1 • ASA Class: 4E

  13. Peri-operative Anesthesiology Note • ASA Class: 4E • General anesthesia (ET tube: 7.5# at 22cm) • Induction at 14:35 with Fentanyl 250 ug, Esmeron 50 mg, Etomidate 20 mg • Maintenance: O2 + Desflurane • Monitors: • Right hand arterial line • Right neck Swan-Ganz • Left neck CVP • Foley catheter

  14. Op Note (5/1) • Pre-op diagnosis: IE, AR, MR, uremia • Post-op diagnosis:IE, AR, MR, uremia • Op method: AVR • Op finding: • Cardiomegaly • Bloody pericardial effusion • Aortic valve: perforation in LCC and RCC, vegetation in NCC ventricular side • No paraaortic abscess, aortic annulus intact • No mitral valve vegetation • Hypertrophy of LV muscle

  15. Duration of anesthesia: 14:35 to 20:35 • Duration of operation: 16:00 to 20:25 • Partial bypass on at 17:02, off at 19:06 • Total bypass on at 17:11, off at 18:53 • Aorta x-clamp on at 17:12, off at 18:37 • ACT: 177 • PRBC 7U, PLT 12U

  16. 體外循環記錄表 • Heparin • To patient: 4.8 cc • To pump: 1.6 cc • Protamine: 6.5ml • Added during CPB • N/S: 1000cc • Blood: 2+2+2 • Vitacal: 20cc • Xylocaine: 8ml+7ml

  17. Heparin Reversal With Protamine • Transient drop in BP and near asystole was noted after initial protamine infusion at 19:10 (BP <50/30 mmHg) • Transient elevation of PAP (>70 mmHg) was also noted • Protamine was held and Epinephrine (Bosmin) 1mg was administered • BP 70/50 mmHg, HR 130 after epinephrine administration

  18. Heparin reversal with protamine continued • Transient drop in BP, HR, and elevation of PAP was noted again • Protamine infusion discontinued • At end of surgery: • ACT: 117 • BT: 37.1 • SpO2: 100 • ETCO2: 34 • PAP: 38/23 • CVP: 10

  19. Post-operative Course • Patient was admitted to 4A2 on 5/1 • Post-op inotropic agents: Dopamine 2amp/250ml, Bosmin 1amp/20ml, Levophed 0.5amp/50ml IVD titration • Smooth extubation on 5/2 • Transferred to 8A ward on 5/4 • Inotropic agents gradually tapered off at ward • Currently, intermittent low grade fever is still noted with mild leukocytosis (WBC 10750) and elevated CRP (5.21), under Vancomycin 500mg Q3D and Amikin 250mg QOD • Hemodialysis T1W

  20. DISCUSSION

  21. Pharmacological Properties of Protamine • Protamine is a polycationic, alkaline protein molecule, and is made up of rich arginine residues. • Heads of the sperm of the salmonidae or clupeidae family as well as man are rich in protamine and salmon milt is the commercial source of protamine. • International Anesthesiology Clinics. 42(3):135-145, Summer 2004

  22. Clinical uses of protamine • Neutralization of heparin use • It forms a stable complex with negatively charged heparin. • Heparin-protamine complex is devoid of anticoagulant activities. • Retardation of insulin absorption in intermediate- and long-acting insulin preparations. • Protamine also exerts a mild anticoagulant activity. • International Anesthesiology Clinics. 42(3):135-145, Summer 2004

  23. 1000X • - Chest. 2001;119(1 suppl):64S–94S

  24. Protamine Reactions • 3 main different categories: • Transient systemic hypotension • Anaphylaxis or anaphylactoid reactions • Catastrophic pulmonary vasoconstriction (0.6%) • Major adverse responses related to protamine administration occur during 2.6% of cardiac surgery procedure. • Hemodynamic perturbations after protamine administration are independently related to in-hospital mortality. • Chest. 2002; 122(3):1061-1066 • Anesthesiology. 2005; 102:308-314

  25. Represent “AUC”: time * ×Δ PAP/ΔSBP • Anesthesiology. 2005; 102:308-314

  26. How does this happen?(1) • Systemic hypotension • Transient systemic hypotension often associated with rapid administration of protamine. • Protamine decreases peripheral vascular resistance rather than depressing myocardial function • Compensatory increased cardiac output • Proposed mechanism: protamine, free or complexed with heparin, acts on endothelial receptors • Chest. 2002, 122(3):1061-1066 • Anesthesia & Analgesia. 1985; 64: 348-361

  27. Chest. 2002, 122(3):1061-1066

  28. How does this happen? (2) • Anaphylaxis or anaphylactoid reaction • As a nonhuman protein, protamine can be antigenic. • It is manifested with decreased SVR, flushing, edema, and bronchospasm. • It is mediated by Ag-specific B-cell (IgE-mediated, anaphylaxis) or direct activation of complement system (non-IgE-mediated, anaphylactoid reaction) • Anesthesia & Analgesia. 1985; 64: 348-361

  29. - From website of University of Sussex, UK

  30. How does this happen?(3) • Catastrophic pulmonary vasoconstriction • Patient presented with pulmonary arterial hypertension, dilated RV, decreased LV filling pressure, and systemic hypotension. • It can occur under various dosage (even low dose at 10 mg) and usually develops in 10 minutes. • The reaction was not seen if protamine was given alone without heparin • International Anesthesiology Clinics. 42(3):135-145, Summer 2004

  31. How does this happen? (4) • Catastrophic pulmonary vasoconstriction • Large increase in plasma C5a and TXB2, but not histamine, in these patients • Proposed mechanism: protamine-heparin complex → complement activation → generation of TXA2 → platelet aggregation and vasoconstriction • Jour of Cardiothoracic and Vascular Anesthesia. 2003, 17(3): 309-313

  32. Who is more susceptible to protamine reactions? • Suspected risk factors: • Fish allergy, not shellfish • Vasectomy and infertility • Prior protamine exposure, eg. DM, vascular surgery • History of pulmonary hypertension • The site of venous protamine administration does not influence incidence of protamine-induced pulmonary vasoconstriction. • Jour of Cardiothoracic and Vascular Anesthesia. 2003, 17(3): 309-313

  33. How to deal with protamine reaction?(1) • Systemic hypotension • Use slow-rate injection • Methylene blue as a NO blocker in refractory cases • Acute anaphylactoid reactions • Diphenhydramine 50 mg IV • Fluid repletion • Epinephrine • Bronchodilators • International Anesthesiology Clinics. 42(3):135-145, Summer 2004 • Chest. 2002, 122(3):1061-1066

  34. How to deal with protamine reaction?(2) • Catastrophic pulmonary vasoconstriction • iNO may be effective • Inodilator such as isoproterenol or milrinone • In patient with known hypersensitivity • Hexadimethrine or heparin removal device as alternative to protamine? • Pretreat with steroid or antihistamine? • The use of aspirin? • Chest. 2002, 122(3):1061-1066 • International Anesthesiology Clinics. 42(3):135-145, Summer 2004

  35. Summary • Protamine reactions appeared with different presentation and can be categorized into 3 main groups: systemic hypotension, anaphylaxis or anaphylactoid reactions, and catastrophic pulmonary hypertension. • These reactions can be associated with adverse outcome of the patients and thus prompt recognition and treatment are important.

  36. Thanks For Your Attention!!

More Related